1. Targeting the Ubiquitin Proteasome System in Cancer
    Nishi Kumari et al, 2018, Neoplasm CrossRef
  2. A review of deubiquitinases and thier roles in tumorigenesis and development
    Xian-Wen Liang et al, 2023, Frontiers in Bioengineering and Biotechnology CrossRef
  3. Alterations of histone modifications in cancer
    Maha M. Saber-Ayad et al, 2024, Epigenetics in Human Disease CrossRef
  4. USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation
    Pingping Hou et al, 2019, Genes & Development CrossRef
  5. Pyrimidine metabolism regulator-mediated molecular subtypes display tumor microenvironmental hallmarks and assist precision treatment in bladder cancer
    Zixuan Wu et al, 2023, Frontiers in Oncology CrossRef
  6. Inhibition of USP21 leads to ovarian carcinoma cell death by suppressing MAPK signaling
    Xin Sun et al, 2024, Biotechnology and Applied Biochemistry CrossRef
  7. Inhibition of glutathione metabolism attenuates esophageal cancer progression
    Liang Peng et al, 2017, Experimental & Molecular Medicine CrossRef
  8. Personalized analysis of breast cancer using sample-specific networks
    Ke Zhu et al, 2020, PeerJ CrossRef
  9. Disulfiram and 6-Thioguanine synergistically inhibit the enzymatic activities of USP2 and USP21
    Hsin-Cheng Lin et al, 2021, International Journal of Biological Macromolecules CrossRef
  10. ZMIZ2 promotes the development of triple-receptor negative breast cancer
    Xiaopan Zou et al, 2022, Cancer Cell International CrossRef
  11. USP21 modulates Goosecoid function through deubiquitination
    Fuwei Liu et al, 2019, Bioscience Reports CrossRef
  12. Deubiquitinases in Cancers: Aspects of Proliferation, Metastasis, and Apoptosis
    Jiaqi LIU et al, 2022, Cancers CrossRef
  13. The emerging role of deubiquitylating enzyme USP21 as a potential therapeutic target in cancer
    Zhen-Yuan Shi et al, 2024, Bioorganic Chemistry CrossRef
  14. Insights Into the Properties, Biological Functions, and Regulation of USP21
    Tao An et al, 2022, Frontiers in Pharmacology CrossRef
  15. LncRNA FGD5‐AS1 can be predicted as therapeutic target in oral cancer
    Longkun Liu et al, 2020, Journal of Oral Pathology & Medicine CrossRef
  16. Development and validation of prognostic index based on purine metabolism genes in patients with bladder cancer
    Zixuan Wu et al, 2023, Frontiers in Medicine CrossRef